Trial Profile
A Study to Evaluate the Efficacy of Prasugrel in Clopidogrel Non-responder Acute Coronary Syndromes (ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms RECLOSE-3
- 24 Feb 2016 New trial record